Screening, Assessment, and Pharmacologic Treatment of Mild Cognitive Impairment and Early Alzheimer's Disease: The Role for Monoclonal Antibodies

Prim Care Companion CNS Disord. 2023 Nov 28;25(6):23f03544. doi: 10.4088/PCC.23f03544.

Abstract

The Psychiatric Consultation Service at Massachusetts General Hospital sees medical and surgical inpatients with comorbid psychiatric symptoms and conditions. During their twice-weekly rounds, Dr Stern and other members of the Consultation Service discuss diagnosis and management of hospitalized patients with complex medical or surgical problems who also demonstrate psychiatric symptoms or conditions. These discussions have given rise to rounds reports that will prove useful for clinicians practicing at the interface of medicine and psychiatry.

Prim Care Companion CNS Disord. 2023;25(6):23f03544.

Author affiliations are listed at the end of this article.

MeSH terms

  • Alzheimer Disease* / complications
  • Alzheimer Disease* / diagnosis
  • Alzheimer Disease* / drug therapy
  • Antibodies, Monoclonal
  • Cognitive Dysfunction* / complications
  • Cognitive Dysfunction* / diagnosis
  • Cognitive Dysfunction* / drug therapy
  • Hospitals, General
  • Humans
  • Mental Disorders* / therapy
  • Psychiatry*
  • Referral and Consultation

Substances

  • Antibodies, Monoclonal